NACL Industries Ltd

NACL Industries Ltd

₹ 57.8 -0.29%
13 Dec 3:12 p.m.
About

NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions. [1] [2]

Key Points

Products[1]
Key technicals:
Insecticides: Cairo, Fenny, Nagarjuna 4G, PestLock, etc.
Herbicides: Font, Slogan, Nagarjuna Combi plus, etc.
Fungicides: Combi plus, Kazan, Result, Subtle Plant Growth Regulators :Atonik, Gallant EG, Gallant Gold
Company has 63 branded products.[2]

  • Market Cap 1,159 Cr.
  • Current Price 57.8
  • High / Low 85.0 / 48.6
  • Stock P/E
  • Book Value 25.4
  • Dividend Yield 0.00 %
  • ROCE -0.04 %
  • ROE -10.8 %
  • Face Value 1.00

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of 7.21% over last 3 years.
  • Company has high debtors of 157 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
443 400 471 475 565 480 599 376 580 365 457 325 440
402 370 431 442 511 443 531 405 550 361 446 329 400
Operating Profit 41 29 40 33 54 38 67 -29 31 4 11 -4 41
OPM % 9% 7% 8% 7% 10% 8% 11% -8% 5% 1% 2% -1% 9%
5 4 2 2 3 3 4 3 1 2 4 3 4
Interest 6 7 7 8 10 12 17 18 20 19 19 18 17
Depreciation 6 6 6 7 7 6 9 7 7 7 7 7 7
Profit before tax 33 20 27 20 40 22 46 -51 6 -20 -11 -27 20
Tax % 27% 29% 25% 26% 25% 25% 27% -25% 28% -22% -19% -23% 27%
24 14 20 15 30 17 34 -38 4 -16 -9 -21 15
EPS in Rs 1.23 0.73 1.03 0.75 1.51 0.83 1.69 -1.91 0.21 -0.80 -0.45 -1.04 0.75
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
601 636 746 692 735 847 865 1,015 1,191 1,633 2,116 1,779 1,588
583 625 701 636 679 798 852 946 1,078 1,495 1,922 1,762 1,536
Operating Profit 18 11 44 56 56 49 14 69 113 138 193 17 51
OPM % 3% 2% 6% 8% 8% 6% 2% 7% 10% 8% 9% 1% 3%
18 16 26 18 41 20 27 8 15 13 10 10 12
Interest 31 28 35 37 38 33 34 29 28 27 47 76 74
Depreciation 25 22 25 27 28 20 20 24 25 25 28 27 28
Profit before tax -20 -23 10 11 31 15 -13 24 75 100 128 -76 -38
Tax % -36% -9% 27% 18% -4% 25% -48% 30% 32% 26% 26% -23%
-13 -21 8 10 33 12 -7 17 51 73 95 -59 -31
EPS in Rs -0.70 -1.32 0.54 0.62 2.09 0.74 -0.42 0.87 2.60 3.70 4.77 -2.96 -1.54
Dividend Payout % 0% 0% 19% 16% 6% 17% 0% 12% 15% 15% 15% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 16%
3 Years: 14%
TTM: -22%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -292%
Stock Price CAGR
10 Years: 17%
5 Years: 18%
3 Years: -11%
1 Year: -20%
Return on Equity
10 Years: 7%
5 Years: 8%
3 Years: 7%
Last Year: -11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 15 16 16 16 16 16 17 19 20 20 20 20 20
Reserves 180 159 162 170 213 223 267 338 399 469 554 491 486
177 219 228 232 213 237 210 268 202 531 724 789 522
228 227 260 193 209 237 248 330 355 496 616 518 617
Total Liabilities 600 621 665 611 651 713 742 955 976 1,516 1,914 1,818 1,645
172 182 176 167 163 158 141 191 220 238 402 439 457
CWIP 11 18 12 6 7 5 21 42 36 116 71 47 29
Investments 4 9 12 13 9 9 14 15 16 13 14 15 15
413 411 466 426 473 541 566 707 704 1,148 1,427 1,318 1,144
Total Assets 600 621 665 611 651 713 742 955 976 1,516 1,914 1,818 1,645

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
76 31 40 46 58 24 36 103 83 -124 -20 50
-5 -47 -18 -12 -6 -14 -27 -97 14 -163 -143 -38
-74 11 -27 -33 -58 -11 -9 70 -113 290 134 -22
Net Cash Flow -3 -5 -4 1 -5 -1 0 77 -16 2 -28 -9

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 100 92 108 99 110 124 113 129 103 118 133 157
Inventory Days 154 140 138 153 189 141 134 84 100 124 112 92
Days Payable 113 97 121 89 127 127 125 137 120 112 110 87
Cash Conversion Cycle 141 135 125 163 172 137 122 76 83 129 135 162
Working Capital Days 97 93 90 119 126 124 125 90 89 123 128 148
ROCE % 3% 2% 11% 12% 10% 11% 4% 10% 17% 15% 15% -0%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
64.16% 64.00% 63.97% 63.97% 63.97% 63.83% 63.83% 63.83% 63.80% 63.72% 63.65% 63.65%
1.85% 1.87% 1.85% 1.87% 1.50% 1.20% 1.16% 1.03% 0.50% 0.28% 0.31% 0.18%
0.00% 0.00% 0.00% 0.00% 0.23% 0.47% 0.81% 0.96% 0.96% 0.96% 0.89% 0.00%
33.99% 34.13% 34.18% 34.14% 34.30% 34.49% 34.20% 34.18% 34.75% 35.04% 35.15% 36.16%
No. of Shareholders 21,64522,85524,07423,91123,65522,95222,44824,81026,94230,81429,56733,089

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls